SkinHealth Systems (SKIN) Operating Leases (2021 - 2026)

SkinHealth Systems (SKIN) has 6 years of Operating Leases data on file, last reported at $18.8 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $18.8 million, up 94.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (up 94.75% YoY), and the FY2025 annual result was $9.2 million, down 42.12% from the prior year.
• Operating Leases grew to $18.8 million in Q1 2026 per SKIN's latest filing, from $9.2 million in the prior quarter.
• Over five years, Operating Leases peaked at $18.8 million in Q1 2026 and troughed at $8.5 million in Q2 2025.
• A 5-year average of $11.9 million and a median of $12.0 million in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2025 and 2026: Operating Leases sank 42.12% in 2025, then soared 94.75% in 2026.
• A 5-year view of Operating Leases shows it stood at $12.7 million in 2022, then slipped by 26.56% to $9.3 million in 2023, then jumped by 71.26% to $16.0 million in 2024, then tumbled by 42.12% to $9.2 million in 2025, then surged by 102.98% to $18.8 million in 2026.
• Business Quant data shows SKIN's Operating Leases at $18.8 million in Q1 2026, $9.2 million in Q4 2025, and $10.6 million in Q3 2025.